Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Variability of Spleen and Mesenteric Lymph Node in Control Cynomolgus Monkeys ( Macaca fascicularis) from Nonclinical Safety Studies: A Retrospective Assessment.

Toxicologic pathology·2018

Same author

Scientific and Regulatory Policy Committee Points to Consider: Data Visualization for Clinical and Anatomic Pathologists.

Toxicologic pathology·2018

Same author

Serum perfluorooctanoic acid (PFOA) concentrations in normal and hyperlipidemic female hamsters dosed orally with ammonium perfluorooctanoate (APFO) for up to 30 days.

Toxicology reports·2017

Same author

Deciphering Sources of Variability in Clinical Pathology-It's Not Just about the Numbers.

Toxicologic pathology·2017

Same author

Deciphering Sources of Variability in Clinical Pathology.

Toxicologic pathology·2016

Same author

Is It Adverse, Nonadverse, Adaptive, or Artifact?

Toxicologic pathology·2016

Search research articles

Related Experiment Video

Updated: Apr 21, 2026

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

Evaluation of clinical pathology data: correlating changes with other study data.

Nancy E Everds¹

¹Amgen Inc, Seattle, Washington, USA neverds@amgen.com.

Toxicologic Pathology

|November 2, 2014

Summary

This summary is machine-generated.

Interpreting toxicology study data requires integrating clinical pathology with other findings. While hemolysis showed strong correlations, liver injury biomarkers were often discordant, highlighting interpretation challenges.

Keywords:

biomarker clinical chemistry clinical pathology data interpretation hematology hemolysis hepatotoxicity safety assessment.

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Related Experiment Videos

Last Updated: Apr 21, 2026

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Area of Science:

Toxicology
Pathology
Biomarkers

Background:

Toxicology studies involve collecting in-life, clinical pathology, and anatomic pathology data.
Interpreting these parameters requires understanding analyte variability and physiologic factors.
Integrative evaluation is crucial for determining test article toxicity.

Purpose of the Study:

To demonstrate the relationships among various parameters and data sets in toxicology studies.
To illustrate how clinical pathology findings correlate with other toxicological data.
To highlight challenges in interpreting biomarkers of organ injury.

Main Methods:

Review of in vivo toxicology study data, including clinical pathology and anatomic pathology.
Analysis of parameters related to hemolysis and hepatotoxicity.
Comparative assessment of concurrent data sets like clinical signs and pathology findings.

Main Results:

Hemolysis in rats showed tight correlation across all data sets (clinical pathology, clinical signs, anatomic pathology).
Hepatotoxicity biomarkers (altered enzymes, other biomarkers) were frequently discordant with other data sets.
Understanding analyte variability is essential for accurate clinical pathology interpretation.

Conclusions:

Integrative analysis of multiple data sets is vital for accurate toxicology assessment.
Discordance in hepatotoxicity data suggests complexity in evaluating liver injury.
Further research into biomarker interpretation and inter-data set correlations is warranted.